Jianguo Yang has nearly 20 years of international biopharma industry experience, including in Abbott Lab ( current Abbiev), MedImmune/Astrozeneca, Genzyme/Sanofi in US and, recently VP/CSO in Qilu Pharmaceutical. As international recognized expert in bioprocess, he achieved world record of high mammalian cell line productivity and published numerous patents and papers. He is an Editorial Advisor and Reviewer of Bioprocess International (Journals), and Executive Director, Sino-America Pharmaceutical Association (SAPA), and reviewer for scientific journals, and a frequently-invited speaker for international conferences. He got his PhD in Cell/Molecular Biology from IlIinois Institute of Technology, US
Biosimilars, Biologics, Biotechnology, Molecular Biology, Protein Purification,GMP.